latest update:
[TrialBase DB]

trial summary · NCT07719608

A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine

Randomized, Double-Blind, Controlled Pivotal Trial of the MySalvia System for the Treatment of Resistant Migraine

Trial record from the TrialBase DB dataset, status RECRUITING, condition Resistant Migraine, sponsored by Salvia BioElectronics. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07719608phase —enrollment 150start 2026-12-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The purpose of this pivotal clinical study is to evaluate the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation therapy, for the preventive treatment of adults with resistant migraine.

Source record: https://clinicaltrials.gov/study/NCT07719608

Facts

registry idNCT07719608
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionResistant Migraine
sponsorSalvia BioElectronics
sponsor classINDUSTRY
enrollment150
start date2026-12-01
primary completion2028-10-01
completion2031-05-01
results postednot reported

Conditions

  • Resistant Migraine
  • Chronic Migraine Headache
  • Headache (Migraine)
  • Headache, Cluster

Interventions

  • Neurostimulator

Countries

  • United States

Intervention types: DEVICE

Work with this record